Nuclease-resistant external guide sequence-induced cleavage of target RNA by human ribonuclease P

Antisense and Nucleic Acid Drug Development

Volumn 8, Issue 5, 1998, Pages 415-426

  Ma, Michael Y X ^a   Jacob Samuel, Biji ^a   Dignam, Jeanne C ^a   Pace, Umberto ^a   Goldberg, Allan R ^a   George, Shaji T ^a  

^a Innovir Laboratories Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUIDE RNA; OLIGORIBONUCLEOTIDE; RIBONUCLEASE P;

ARTICLE; CHEMICAL MODIFICATION; GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; NUCLEOTIDE SEQUENCE; PRECURSOR; PRIORITY JOURNAL; RNA CLEAVAGE;

EID: 0031796586     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.1.1998.8.415     Document Type: Article

References (33)

1. ALTMAN, S. (1993). RNA enzyme-directed gene therapy. Proc. Natl. Acad. Sci. USA 90, 10898-10900.
2. BARTKIEWICZ, M., GOLD, H., and ALTMAN, S. (1989). Identification and characterization of an RNA molecule that copurifies with RNase P activity from HeLa cells. Genes Dev. 3, 488-499.
3. BEIGELMAN, L., McSWIGGEN, J.A., DRAPER, K.G., GONZALEZ, C., JENSEN, K., KARPEISKY, A.M., MODAK, A.S., MATULIC-ADAMIC, J., DIRENZO, A.B., HAEBERLI, P., SWEEDLER, D., TRACZ, D., GRIMM, S., WINCOTT, F.E., THACKARAY, V.G., and USMAN, N. (1995). Chemical modification of hammerhead ribozymes. Catalytic activity and nuclease resistance. J. Biol. Chem. 270, 25702-25708.
4. BERGOT, B.J., and EGAN, W. (1992). Separation of synthetic phosphorothioate oligodeoxynucleotides from their oxygenated(phosphodiester) defect species by strong-anion-exchange high-performance liquid chromatography. J. Chromatogr. 599, 35-42.
5. CECH, T.R. (1993). Structure and mechanism of the large catalytic RNAs: Group I and group II introns and ribonuclease P. In: The RNA World. R.F. Gresteland and J.F. Atkins, eds. (Cold Spring Harbor Laboratory Press, New York), pp. 239-269.
6. CROOKE, S.T., and BENNETT, C.F. (1996). Progress in antisense oligonucleotide therapeutics. Annu. Rev. Pharmacol. Toxicol. 36, 107-129.
7. CUMMINS, L.L., OWENS, S.R., RISEN, L.M., LESNIK, E.A., FREIER, S.M., McGEE, D., GUINOSSO, C.J., and COOK, P.D. (1995). Characterization of fully 2′-modified olioribonucleotide hetero- and homoduplex hybridization and nuclease sensitivity. Nucleic Acids Res. 23, 2019-2024.
8. DESJARDINS, J.P., SPROAT, B.S., BEIJER, B., BLASCHKE, M., DUNKEL, M., GERDES, W., LUDWIG, J., REITHER, V., RUPP, T., and IVERSEN, P.L. (1996). Pharmacokinetics of a synthetic, chemically modified hammerhead ribozyme against the rat cytochrome P-450 3A2 mRNA after single intravenous injections. J. Pharmacol. Exp. Ther. 278, 1419-1427.
9. FERSHT, A. (1977). Enzyme Structure and Mechanism. (Freeman Press, San Francisco, CA), p. 90.
10. FLORY, C.M., PAVCO, P.A., JARVIS, T.C., LESCH, M.E., WINCOTT, F.E., BEIGELMAN, L., HUNT, S.W., and SCHRIER, D.J. (1996). Nuclease-resistant ribozymes decrease stromelysin mRNA levels in rabbit synovium following exogenous delivery to the knee joint. Proc. Natl. Acad. Sci. USA 93, 754-758.
11. FORSTER, A.C., and ALTMAN, S. (1990). External guide sequences for an RNA enzyme. Science 249, 783-786.
12. HARTMANN, R.K., KRUPP, G., and HARDT, W.-D. (1995). Towards a new concept of gene inactivation: Specific RNA cleavage by endogenous ribonuclease P. Biotech. Annu. Rev. 1, 215-265.
13. HEIDENREICH, O., BENSELER, F., FAHRENHOLZ, A., and ECKSTEIN, F. (1994). High activity and stability of hammerhead ribozymes containing 2′-modified pyrimidine nucleosides and phosphorothioates. J. Biol. Chem. 269, 2131-2138.
14. INOUE, H., HAYASE, Y., ASAKA, M., IMURA, A., IWAI, S., MIURA, K., and OHTSUKA, E. (1985). Synthesis and properties of novel nucleic acid probes. Nucleic Acids Res. Symp. Ser. 16, 165-168.
15. IYER, R.P., PHILLIPS, L.R., EGAN, W., REGAN, J.B., and BEAUCAGE, S.L. (1990). The automated synthesis of sulfur-containing oligodeoxyribonucleotides using 3H-1,2-benzodithiol-3-one 1,1-dioxide as a sulfur-transfer reagent. J. Org. Chem. 55, 4693-4701.
16. KAZAKOV, S., and ALTMAN, S. (1991). Site-specific cleavage by metal ion cofactors and inhibitors of M1 RNA, the catalytic subunit of RNase P from Escherichia coli. Proc. Natl. Acad. Sci. USA 88, 9193-9197.
17. LEEDS, J.M., GRAHAM, M.J., TRUONG, L., and CUMMINS, L.L. (1996). Quantitation of phosphorothioate oligonucleotides in human plasma. Anal. Biochem. 235, 36-43.
18. LESNIK, E.A., GUINOSSO, C.J., KAWASAKI, A.M., SASMOR, H., ZOUNES, M., CUMMINS, L.L., ECKER, D.J., COOK, P.D., and FREIER, S.M. (1993). Oligodeoxynucleotides containing 2′-O-modified adenosine: Synthesis and effects on stability of DNA:RNA duplexes. Biochemistry 32, 7832-7838.
19. LORIA, A., and PAN, T. (1997). Recognition of the T stem-loop of a pre-tRNA substrate by ribozyme from Bacillus substilis ribonuclease P. Biochemistry 36, 6317-6325.
20. MATTEUCCI, M.D., and WAGNER, R.W. (1996). In pursuit of antisense. Nature 384 (Suppl), 20-22.
21. MONIA, B.P., LESNIK, E.A., GONZALEZ, C., LIMA, W.F., McGEE, D., GUINOSSO, C.J., KAWASAKI, A.M., COOK, P.D., and FREIER, S.M. (1993). Evaluation of 2′-modified oligonucleotides containing 2′-deoxy gaps as antisense inhibitors of gene expression. J. Biol. Chem. 268, 14514-14522.
22. ORTIGÃO, J.F.R., RÖSCH, H., SELTER, H., FRÖHLICH, A., LORENZ, A., MONTENARH, M., and SELIGER, H. (1992). Antisense effect of oligodeoxynucleotides with inverted terminal internucleotidic linkages: A minimal modification protecting against nucleolytic degradation. Antisense Res. Dev. 2, 129-146.
23. PACE, N.R., and BROWN, J.W. (1995). Evolutionary perspective on the structure and function of ribonuclease P, a ribozyme. J. Bacteriol. 177, 1919-1928.
24. PAOLELLA, G., SPROAT, B.S., and LAMOND, A.I. (1992). Nuclease resistant ribozymes with high catalytic activity. EMBO J. 11, 1913-1919.
25. PEYMAN, A., and UHLMANN, E. (1996). Minimally modified oligonucleotides - Combination of end-capping and pyrimidine-protection. Biol. Chem. Hoppe-Seyler 377, 67-70.
26. ROBERTUS, J.D., LADNER, J.E., FINCH, J.T., RHODES, D., BROWN, R.S., CLARK, B.F.C., and KLUG, A. (1974). Structure of yeast phenylalanine tRNA at 3 A resolution. Nature 250, 546-551.
27. SCARINGE, S.A., FRANKLYN, C., and USMAN, N. (1990). Chemical synthesis of biologically active oligoribonucleotides using beta-cyanoethyl protected ribonucleoside phosphoramidites. Nucleic Acids Res. 18, 5433-5441.
28. SINHA, N.D., DAVIS, P., USMAN, N., PEREZ, J., HODGE, R., KREMSKY, J., and CASALE, R. (1993). Labile exocyclic amine protection of nucleosides in DNA, RNA, and oligonucleotide analog synthesis facilitating N-deacylation, minimizing depurination and chain degradation. Biochimie 75, 13-23.
29. SPROAT, B., COLONNA, F., MULLAH, B., TSOU, D., ANDRUS, A., HAMPEL, A., and VINAYAK, R. (1995). An efficient method for the isolation and purification of oligoribonucleotides. Nucleosides Nucleotides 14, 255-273.
30. THURLOW, D.L., SHILOWSKI, D., and MARSH, T.L. (1991). Nucleotides in precursor tRNAs that are required intact for catalysis by RNase P RNAs. Nucleic Acids Res. 19, 885-891.
31. WINCOTT, F.E., DIRENZO, A., SHAFFER, C. GRIMM, S., TRACZ, D., WORKMAN, C., SWEEDLER, D., GONZALEZ, C., SCARINGE, S., and USMAN, N. (1995). Synthesis, deprotection, analysis and purification of RNA and ribozymes. Nucleic Acids Res. 23, 2677-2684.
32. YUAN, Y., and ALTMAN, S. (1995). Substrate recognition by human RNase P: Identification of small, model substrates for the enzyme. EMBO J. 14, 159-168.
33. YUAN, Y., HWANG, E., and ALTMAN, S. (1992). Targeted cleavage of mRNA by human RNase P. Proc. Natl. Acad. Sci. USA 89, 8006-8010.